Skip to main content
Equibles
CCXI logo

CCXI · Churchill Capital Corp XI

Track CCXI — free

Use CCXI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CCXI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.99 +0.37 (+3.18%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has determined that the liquidity condition raises substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$686.78M
Shares
55.70M
Volume · Oct 2 2.13M Avg daily vol (3M) 2.72M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$11.99 Open$11.80 Day$11.71–12.15 Available close range$10.09–19.10 Avg vol 30d2.0M Short int4.2M · 7.5% float · 2.1d Short vol32% DataFeb 2026–Oct 2026 Filing10-Q · Aug 13

The closing range uses available history since Feb 9, 2026; less than a full year is stored.

Up next

Latest filing: 10-Q
filed Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.25M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
7.5%
Latest settlement · 2.1 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −14%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 21%
mid-range
Momentum
relative strength
Strong
1-month return −13%
trailing
6-month return +18%
trailing
Relative strength +6%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+4% holders QoQ · +31 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
7.54% of float · ▲ +12.7% MoM · 2.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
77 holders — 13F breadth
Squeeze score 59
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 61%
annualized · 1-yr
Max drawdown −39%
past year
ATR 6.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−14% Bearish
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
21% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+4% holders QoQ · +31 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
7.54% of float · ▲ +12.7% MoM · 2.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
77 holders — 13F breadth
Price context
position in its available closing range
Range low $10 Now $12 · 21% Range high $19
vs 50-day avg -14%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CCXI
Churchill Capital Corp XI
this stock
$686.78M — — — 7.5%
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
 $649.10M +2.9% — — 0.2%
EVAC
EQV Ventures Acquisition Corp. II
 $602.60M +2.8% — — 0.0%
BCSS
Bain Capital GSS Investment Corp.
 $600.94M +2.0% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
77
% held
57.8%
Net QoQ
-10.9M sh
Top holder
Empyrean Capital Partners…
Held Float
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Rising
Shares short
4.2M
Days to cover
2.1d
Change
+472.5K sh
View
Short Volume
Short vol %
32%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
1.4K
Value
$18.1K
As of
Sep 10, 2026
View
Off-Exchange
Off-exchange %
54.2%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Josh Gottheimer
Amount
$1.0K–$15.0K
Traded
Dec 2, 2021
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 13, 2026
This year
9
View

Performance

5D 20D 120D MTD YTD
CCXI -3.5% -13.2% +17.9% +3.2% —
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -3.3% -12.8% +5.7% +2.3% —
Key facts CIK 2074973 CUSIP G2131A108 13F (30d) 2 filings 2 filers Visit website Investor relations